P. Lederlin

发表

Tumor necrosis factor alpha release is a major biological event associated with rituximab treatment.

G. Salles, B. Coiffier, O. Casasnovas, 2001, The hematology journal : the official journal of the European Haematology Association.

Elderly patients with aggressive non-Hodgkin's lymphoma: disease presentation, response to treatment, and survival--a Groupe d'Etude des Lymphomes de l'Adulte study on 453 patients older than 69 years.

J. Blay, B. Coiffier, H. Tilly, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Chemotherapy plus involved-field radiation in early-stage Hodgkin's disease.

J. Raemaekers, A. Hagenbeek, G. Salles, 2007, The New England journal of medicine.

Effect of granulocyte colony-stimulating factor administration in elderly patients with aggressive non-Hodgkin's lymphoma treated with a pirarubicin-combination chemotherapy regimen. Groupe d'Etudes des Lymphomes de l'Adulte.

B. Coiffier, H. Tilly, C. Gisselbrecht, 1996, Annals of oncology : official journal of the European Society for Medical Oncology.

Characteristics and outcome of diffuse large B-cell lymphoma in hepatitis C virus-positive patients in LNH 93 and LNH 98 Groupe d'Etude des Lymphomes de l'Adulte programs.

P. Gaulard, B. Coiffier, H. Tilly, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[Acute leukemia secondary to the treatment of multiple sclerosis with chlorambucil].

T. Conroy, P. Lederlin, F. Streiff, 1985, Revue neurologique.

Leukaemic small cell variant anaplastic large cell lymphoma during pregnancy.

M. Béné, E. Labouyrie, P. Lederlin, 2000, Clinical and laboratory haematology.

Hepatosplenic γδ T-cell Lymphoma is a Rare Clinicopathologic Entity with Poor Outcome : Report on a Series of 21 Cases . Short title : HEPATOSPLENIC γδ T-CELL LYMPHOMA

P. Gaulard, H. Tilly, E. Labouyrie, 2003 .

Hematologic recovery after autologous PBPC transplantation: importance of the number of postthaw CD34+ cells

P. Feugier, C. Janot, D. Bensoussan, 2003, Transfusion.

Incidence and risk factors for central nervous system occurrence in elderly patients with diffuse large-B-cell lymphoma: influence of rituximab.

T. Molina, B. Coiffier, P. Feugier, 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

Incidence and risk factors of central nervous system relapse in histologically aggressive non-Hodgkin's lymphoma uniformly treated and receiving intrathecal central nervous system prophylaxis: A GELA study on 974 patients

H. Tilly, É. Lepage, C. Haioun, 2000 .

A multivariate analysis of the survival of patients with aggressive lymphoma: variations in the predictive value of prognostic factors during the course of the disease. Groupe d'Etudes des Lymphomes de l'Adulte.

B. Coiffier, H. Tilly, C. Gisselbrecht, 1998, Cancer.

Superiority of late over early intensification in relapsing/refractory aggressive non-Hodgkin's lymphoma: A randomized study from the GELA: LNH RP 93

G. Salles, B. Coiffier, H. Tilly, 1997 .

[Realization of an assisted system for medical decision and follow-up in hematologic diseases treated with sequential chemotherapy].

P. Lederlin, A. Guerci, F. Witz, 1990, La Revue de medecine interne.

Is the small non-cleaved-cell lymphoma histologic subtype a poor prognostic factor in adult patients? A case-controlled analysis. The Groupe d'Etude des Lymphomes de l'Adulte.

B. Coiffier, H. Tilly, É. Lepage, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[Granulocyte sarcoma of the pancreas without extra-pancreatic location].

P. Feugier, E. Labouyrie, P. Lederlin, 2002, Presse medicale.

Single Treatment with Rituximab Monotherapy for Low-Tumor Burden Follicular Lymphoma (FL): Survival Analyses with Extended Follow-Up (F/Up) of 7 Years.

G. Salles, H. Tilly, N. Brousse, 2006 .

[Actinomycosis and non-Hodgkin's malignant lymphoma: fortuitous association?].

P. Lederlin, F. Mory, A. Blum, 1996, La Revue de medecine interne.

Shortened first-line high-dose chemotherapy for patients with poor-prognosis aggressive lymphoma.

T. Molina, B. Coiffier, H. Tilly, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Shortened Firs t-Line High-Dose Chemotherapy for Pat ients With Poor-Prognosis Aggress ive Lymphoma

T. Molina, B. Coiffier, H. Tilly, 2002 .

A multivariate analysis of the survival of patients with aggressive lymphoma

B. Coiffier, H. Tilly, C. Gisselbrecht, 1998 .

Primary anaplastic large-cell lymphoma in adults: clinical presentation, immunophenotype, and outcome.

P. Gaulard, F. Berger, J. Diebold, 1997, Blood.

Benefit of autologous bone marrow transplantation over sequential chemotherapy in poor-risk aggressive non-Hodgkin's lymphoma: updated results of the prospective study LNH87-2. Groupe d'Etude des Lymphomes de l'Adulte.

P. Gaulard, B. Coiffier, H. Tilly, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

De novo methylation of tumour suppressor genes CDKN2A and CDKN2B is a rare finding in B‐cell chronic lymphocytic leukaemia

P. Jonveaux, P. Lederlin, V. Martel, 1997, British journal of haematology.

Rituximab plus CHOP (R-CHOP) overcomes bcl-2--associated resistance to chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL).

P. Gaulard, F. Berger, B. Coiffier, 2003, Blood.

Prognosis of patients with advanced hodgkin's disease

F. Berger, É. Lepage, P. Lederlin, 1997, Cancer.

High efficacy of recombinant urate oxidase in prevention of renal failure related to tumor lysis syndrome (TLS).

G. Leverger, C. Patte, J. Boos, 1998 .

Rituximab (anti-CD20 monoclonal antibody) as single first-line therapy for patients with follicular lymphoma with a low tumor burden: clinical and molecular evaluation.

G. Salles, A. Stamatoullas, N. Brousse, 2001, Blood.

CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.

Pierre Morel, Raoul Herbrecht, Felix Reyes, 2002, The New England journal of medicine.

ACVBP versus CHOP plus radiotherapy for localized aggressive lymphoma.

T. Molina, B. Coiffier, H. Tilly, 2005, The New England journal of medicine.

Intensive salvage therapy with high-dose chemotherapy for patients with advanced Hodgkin's disease in relapse or failure after initial chemotherapy: results of the Groupe d'Etudes des Lymphomes de l'Adulte H89 Trial.

G. Salles, F. Berger, A. Stamatoullas, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Survival benefit of high-dose therapy in poor-risk aggressive non-Hodgkin's lymphoma: final analysis of the prospective LNH87-2 protocol--a groupe d'Etude des lymphomes de l'Adulte study.

P. Gaulard, G. Salles, B. Coiffier, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Comparison of chemotherapy to radiotherapy as consolidation of complete or good partial response after six cycles of chemotherapy for patients with advanced Hodgkin's disease: results of the groupe d'études des lymphomes de l'Adulte H89 trial.

F. Berger, C. Sebban, É. Lepage, 2000, Blood.

Randomized comparison of ACVBP and m-BACOD in the treatment of patients with low-risk aggressive lymphoma: the LNH87-1 study. Groupe d'Etudes des Lymphomes de l'Adulte.

B. Coiffier, H. Tilly, P. Biron, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Hepatosplenic γδ T-cell lymphoma is a rare clinicopathologic entity with poor outcome: report on a series of 21 patients

P. Gaulard, H. Tilly, E. Labouyrie, 2003 .

Hepatosplenic gammadelta T-cell lymphoma is a rare clinicopathologic entity with poor outcome: report on a series of 21 patients.

P. Gaulard, H. Tilly, E. Labouyrie, 2003, Blood.

Long-term outcome with pentostatin treatment in hairy cell leukemia patients. A French retrospective study of 238 patients

B. Coiffier, B. Grosbois, C. Sebban, 2003, Leukemia.

Cimetidine for pruritus in Hodgkin's disease.

P. Lederlin, J. Aymard, F. Witz, 1980, British medical journal.

Intravascular bone marrow accumulation in persistent polyclonal lymphocytosis: a misleading feature for B-cell neoplasm

P. Feugier, M. Béné, E. Labouyrie, 2004, Modern Pathology.

H. Tilly, É. Lepage, C. Haioun, 2000, Annals of oncology : official journal of the European Society for Medical Oncology.

Acute myelogenous leukaemia followed by non-Hodgkin's lymphoma in a patient with AIDs.

P. Lederlin, C. Rabaud, J. Paitel, 1995, The Journal of infection.

Multiple myeloma after phenytoin therapy.

P. Lederlin, G. Faure, J. Aymard, 2009, Scandinavian journal of haematology.

90Yttrium ibritumomab tiuxetan (Zevalin) combined with BEAM (Z-BEAM) conditioning regimen plus autologous stem cell transplantation in relapsed or refractory. follicular lymphoma. GELA phase II study

B. Coiffier, H. Tilly, C. Gisselbrecht, 2007 .

Autologous stem-cell transplantation as consolidation therapy for diffuse large B-cell lymphoma patients with overexpression of bcl-2 protein. Results of the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trial LNH98-B2.

P. Gaulard, G. Salles, M. Copin, 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

A weekly regimen with dose escalation of doxorubicin for patients with advanced Hodgkin's lymphoma: Results of a phase II study of the Groupe d'Études des Lymphomes de l'Adulte (GELA)

O. Casasnovas, N. Mounier, P. Lederlin, 2007, Leukemia & lymphoma.

Plasma cytokine and soluble receptor signature predicts outcome of patients with classical Hodgkin's lymphoma: a study from the Groupe d'Etude des Lymphomes de l'Adulte.

J. Blay, G. Salles, A. Stamatoullas, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Paludisme post-transfusionnelUn cas de double infestation à plasmodium falciparum et plasmodium malari˦

P. Lederlin, É. Vinet, F. Witz, 1980 .

[Gelatinous transformation of the bone marrow. Apropos of 3 cases].

P. Feugier, P. Lederlin, F. Boman, 1995, La Revue de medecine interne.

Epstein-Barr virus lymphoproliferative disease of donor origin after kidney transplantation: a case report.

M. Kessler, P. Lederlin, A. Bellou, 1995, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[Splenectomy under celioscopy].

P. Lederlin, L. Bresler, P. Boissel, 1995, Annales de chirurgie.

Phase II study of 3-hour infusion of high dose paclitaxel in refractory and relapsed aggressive non-Hodgkin's lymphomas. Groupe d'Etude des Lymphomes de l'Adulte.

J. Blay, A. Stamatoullas, B. Quesnel, 2000, Haematologica.

Phase II study of 3-hour infusion of high dose paclitaxel in refractory and relapsed aggressive non-Hodgkin ' s lymphomas

A. Stamatoullas, B. Quesnel, C. Haioun, 2000 .

Late cardiopulmonary toxicity after treatment for Hodgkin's disease.

T. Conroy, P. Lederlin, P. Bey, 1992, British Journal of Cancer.

Rituximab Combined to ACVBP (R-ACVBP) as a New Inductive Treatment Followed by High-Dose Consolidative Autotransplantation (HDC) for Poor Risk Diffuse Large B-Cell Lymphoma (DLBCL) in First-Line. Preliminary Results on 119 Patients of a GELA Phase II Study.

B. Coiffier, O. Casasnovas, H. Tilly, 2006 .

Acute leukaemia after prolonged chlorambucil treatment for non-malignant disease: report of a new case and literature survey.

P. Lederlin, J. Aymard, F. Witz, 1980, Acta haematologica.

[Post-transfusional malaria: a case of double infection with Plasmodium falciparum and Plasmodium malariae].

P. Lederlin, É. Vinet, J. Aymard, 1980, Revue francaise de transfusion et immuno-hematologie.

Acute leukaemia following prolonged chlorambucil treatment for non-neoplastic disease - a study of two cases and literature review.

P. Lederlin, F. Streiff, J. Buisine, 1983, Acta clinica Belgica.

Fatal agranulocytosis in sulfasalazine treated rheumatoid arthritis.

F. Guillemin, P. Lederlin, P. Tréchot, 1989, Journal of Rheumatology.

Safety of prophylactic use of darbepoetin alfa in patients with diffuse large B-Cell lymphoma (DLBCL) treated with R-CHOP 14 or RCHOP21: Preliminary results of the LNH03-6B randomized GELA study.

B. Coiffier, H. Tilly, C. Gisselbrecht, 2006 .

Prognosis of patients with advanced hodgkin's disease

F. Berger, É. Lepage, P. Lederlin, 1997, Cancer.

Sarcomes du cœur

P. Lederlin, P. Bey, J. Neimann, 1985 .